Literature DB >> 20182345

Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.

Rajal B Shah1, Cristina Magi-Galluzzi, Bo Han, Ming Zhou.   

Abstract

Atypical cribriform lesions of the prostate (ACL) are cribriform glands lined by cytologically malignant cells with partial or complete basal cell lining. They represent cribriform high-grade PIN (cribriform HGPIN), which can be an isolated finding not associated with PCa (isolated ACL), or "intraductal carcinoma (IDC-P)" that is almost always associated with infiltrative high-grade prostate carcinoma (PCa) (cancer-associated ACL, ACL-PCa). We report the incidence, topographic relation to cancer, and morphologic differences of these 2 lesions in radical prostatectomy and discuss the potential biologic basis and implication for diagnosis in prostate biopsy. ACL was defined as cribriform glands comprising cytologically malignant cells that spanned the entire glandular lumens with partial or complete basal cell lining confirmed by basal cell immunostaining. ACL intermixed with, or within 3 mm from the border of infiltrative PCa was categorized as ACL-PCa and was considered to be equivalent to IDC-P. ACLs other than ACL-PCa were considered as isolated ACL and equivalent to cribriform HGPIN. These histologic features of ACL were reviewed: number of ACL/prostate gland, size, glandular contour (round, irregular, branching), architectural pattern (dense cribriform, irregular cribriform, solid), comedonecrosis, and nuclear features (round and uniform, round with varying sizes, pleomorphic, giant nuclei [6x adjacent nuclei]). In 117 consecutive radical prostatectomy specimens, ACL-PCa and isolated ACLs were found in 21 (17.9%) and 15 (12.8%), respectively. ACL-PCa was more common in PCa with Gleason score more than or equal to 7 and higher tumor volume. The isolated ACLs were more common in Gleason score 6 PCa and their incidence was not significantly different among PCa with different tumor volumes. The mean number of ACL per prostate was 23.8 for ACL-PCa and 2.4 for isolated ACL (P=0.008). The size ranged from 0.2 to 9.0 mm for ACL-PCa, and from 0.2 to 1 mm for isolated ACL. The branching contour was present in 36/43 ACL-PCa, but only in 1/23 isolated ACL (P<0.001). The dense cribriform and solid architecture were present in 6 (14.0%) and 4 (9.3%) of ACL-PCa, but none of the isolated ACLs. Comedonecrosis was present in 14/43 (32.6%) ACL-PCa, and in none of the isolated ACL (P=0.001). The pleomorphic nuclei or giant nuclei at least 6X of the adjacent nuclei, were present in 12 (27.9%) ACL-PCa, but in none of the isolated ACL (P=0.005). ACL can be found both in association with PCa or without associated infiltrative PCa. Isolated ACL is uncommon, and the overwhelming majority of ACLs is associated with high grade (GS> or =7) and high-volume PCa and represents IDC-P. Large gland size (>1 mm), large focus involving many glands (number>6), complex architecture, and high-grade nuclei are characteristic of IDC-P. However, cribriform HGPIN and IDC-P overlap at the "low grade" architectural and morphologic spectrum and are difficult to distinguish based on morphologic criteria alone. If a biopsy contains a small number of ACL glands with "low grade" morphology, it should be diagnosed as "atypical cribriform lesion, cannot distinguish between cribriform HGPIN and IDC-P" and a repeat biopsy should be strongly recommended to rule out unsampled PCa. In contrast, if a biopsy contains ACL with one or several features of large focus, architectural complexity with large branching glands, pleomorphic or giant nuclei, or comedonecrosis, the biopsy should be diagnosed as IDC-P and definitive therapy should be recommended.

Entities:  

Mesh:

Year:  2010        PMID: 20182345     DOI: 10.1097/PAS.0b013e3181cfc44b

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

1.  Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.

Authors:  Kosuke Miyai; Mukul K Divatia; Steven S Shen; Brian J Miles; Alberto G Ayala; Jae Y Ro
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 2.  Intraductal carcinoma of prostate (IDC-P): from obscure to significant.

Authors:  Ni Chen; Qiao Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

3.  Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.

Authors:  Ekaterina Olkhov-Mitsel; Farshid Siadat; Ken Kron; Liyang Liu; Andrea J Savio; John Trachtenberg; Neil Fleshner; Theodorus van der Kwast; Bharati Bapat
Journal:  Oncol Lett       Date:  2017-05-09       Impact factor: 2.967

Review 4.  Intraductal carcinoma of prostate: a comprehensive and concise review.

Authors:  Jordan A Roberts; Ming Zhou; Yong Wook Park; Yong Wok Park; Jae Y Ro
Journal:  Korean J Pathol       Date:  2013-08-26

Review 5.  [Intraductal carcinoma of the prostate].

Authors:  G Kristiansen; M Varma; G Seitz
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

6.  Comedonecrosis Revisited: Strong Association With Intraductal Carcinoma of the Prostate.

Authors:  Samson W Fine; Hikmat A Al-Ahmadie; Ying-Bei Chen; Anuradha Gopalan; Satish K Tickoo; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2018-08       Impact factor: 6.394

7.  Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.

Authors:  Carlos L Morais; Jeong S Han; Jennifer Gordetsky; Michael S Nagar; Ann E Anderson; Stephen Lee; Jessica L Hicks; Ming Zhou; Cristina Magi-Galluzzi; Rajal B Shah; Jonathan I Epstein; Angelo M De Marzo; Tamara L Lotan
Journal:  Am J Surg Pathol       Date:  2015-02       Impact factor: 6.394

8.  Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.

Authors:  Michael C Haffner; Christopher Weier; Meng Meng Xu; Ajay Vaghasia; Bora Gürel; Berrak Gümüşkaya; David M Esopi; Helen Fedor; Hsueh-Li Tan; Ibrahim Kulac; Jessica Hicks; William B Isaacs; Tamara L Lotan; William G Nelson; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  J Pathol       Date:  2015-10-14       Impact factor: 7.996

Review 9.  Intraductal Carcinoma of the Prostate Gland: Recent Advances.

Authors:  Mukul K Divatia; Jae Y Ro
Journal:  Yonsei Med J       Date:  2016-09       Impact factor: 2.759

10.  Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.

Authors:  Tamara L Lotan; Berrak Gumuskaya; Hameed Rahimi; Jessica L Hicks; Tsuyoshi Iwata; Brian D Robinson; Jonathan I Epstein; Angelo M De Marzo
Journal:  Mod Pathol       Date:  2012-12-07       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.